These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19139004)

  • 1. Tamoxifen prevents premalignant changes of breast, but not ovarian, cancer in rats at high risk for both diseases.
    Ting AY; Kimler BF; Fabian CJ; Petroff BK
    Cancer Prev Res (Phila); 2008 Dec; 1(7):546-53. PubMed ID: 19139004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
    Ting AY; Kimler BF; Fabian CJ; Petroff BK
    Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.
    Namba R; Young LJ; Maglione JE; McGoldrick ET; Liu S; Wurz GT; DeGregorio MW; Borowsky AD; MacLeod CL; Cardiff RD; Gregg JP
    Breast Cancer Res; 2005; 7(6):R881-9. PubMed ID: 16280035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNP-470 inhibits 7,12-dimethylbenz[a]anthracene-induced mammary tumor formation when administered before the formation of carcinoma in situ but is not additive with tamoxifen.
    Heffelfinger SC; Gear RB; Schneider J; LaDow K; Yan M; Lu F; Pyle AL; Warshawsky D
    Lab Invest; 2003 Jul; 83(7):1001-11. PubMed ID: 12861040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female Sprague-Dawley rats.
    Kubatka P; Bojková B; M ciková-Kalická K; Mníchová-Chamilová M; Adámeková E; Ahlers I; Ahlersová E; Cermáková M
    Folia Biol (Praha); 2001; 47(1):5-10. PubMed ID: 11232869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tamoxifen on preneoplastic cell proliferation in N-nitroso-N-methylurea-induced mammary carcinogenesis.
    Osborne MP; Ruperto JF; Crowe JP; Rosen PP; Telang NT
    Cancer Res; 1992 Mar; 52(6):1477-80. PubMed ID: 1540955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strain differences in tamoxifen sensitivity of Sprague-Dawley and Fischer 344 rats.
    Bailey JA; Nephew KP
    Anticancer Drugs; 2002 Oct; 13(9):939-47. PubMed ID: 12394257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tamoxifen on mammary preneoplasia: relevance to chemopreventive intervention.
    Telang NT; Bradlow HL; Osborne MP
    Cancer Detect Prev; 1994; 18(4):313-21. PubMed ID: 7982241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
    Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
    Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of chemopreventive agents on estradiol metabolism and mammary preneoplasia in the C3H mouse.
    Osborne MP; Telang NT; Kaur S; Bradlow HL
    Steroids; 1990 Mar; 55(3):114-9. PubMed ID: 2139751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator.
    McDougal A; Wormke M; Calvin J; Safe S
    Cancer Res; 2001 May; 61(10):3902-7. PubMed ID: 11358803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness of
    Alothman SJ; Wang W; Goerlitz DS; Islam M; Zhong X; Kishore A; Azhar RI; Kallakury BV; Furth PA
    Cancer Prev Res (Phila); 2017 Apr; 10(4):244-254. PubMed ID: 28283467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: evidence for estrogen receptor mediation.
    Li SA; Weroha SJ; Tawfik O; Li JJ
    J Endocrinol; 2002 Nov; 175(2):297-305. PubMed ID: 12429028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of omega-3 fatty acids on Tamoxifen-induced suppression of rat mammary carcinogenesis.
    Manni A; Richie JP; Xu H; Washington S; Aliaga C; Bruggeman R; Cooper TK; Prokopczyk B; Trushin N; Calcagnotto A; Das A; Liao J; El-Bayoumy K
    Int J Cancer; 2014 Apr; 134(7):1549-57. PubMed ID: 24122252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibitory effect of tamoxifen on the breast cancer risk induced by exogenous estrogen in rat].
    Zeng X; Yao Z
    Zhonghua Wai Ke Za Zhi; 1996 Mar; 34(3):176-9. PubMed ID: 9387675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of SERM (selective estrogen receptor modulator) treatment on growth and proliferation in the rat uterus.
    Stygar D; Muravitskaya N; Eriksson B; Eriksson H; Sahlin L
    Reprod Biol Endocrinol; 2003 May; 1():40. PubMed ID: 12777179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-bromo-alpha-ergocryptine (CB-154) and tamoxifen (ICI 46,474) induced suppression of the genesis of mammary carcinomas in female rats treated with 7,12-dimethylbenzanthracene (DMBA): a comparison.
    Welsch CW; Goodrich-Smith M; Brown CK; Mackie D; Johnson D
    Oncology; 1982; 39(2):88-92. PubMed ID: 6801566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Flaxseed Lignan Secoisolariciresinol Diglucosideon Preneoplastic Biomarkers of Cancer Progression in a Model of Simultaneous Breast and Ovarian Cancer Development.
    Delman DM; Fabian CJ; Kimler BF; Yeh H; Petroff BK
    Nutr Cancer; 2015; 67(5):857-64. PubMed ID: 26010915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of tamoxifen and the rexinoid LG100268 prevents ER-positive and ER-negative mammary tumors in p53-null mammary gland mice.
    Mazumdar A; Medina D; Kittrell FS; Zhang Y; Hill JL; Edwards DE; Bissonnette RP; Brown PH
    Cancer Prev Res (Phila); 2012 Oct; 5(10):1195-202. PubMed ID: 22926341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats.
    Sylvester PW; Ip C; Ip MM
    Cancer Res; 1986 Feb; 46(2):763-9. PubMed ID: 3079669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.